The DOI matches its Crossref record.
Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor
Abstract
The overzealous production of pro-inflammatory cytokines during endotoxemia can result in shock, multiorgan dysfunction, and even death. The extent of tissue injury that occurs in endotoxemia is determined not only by the release of pro-inflammatory cytokines, but also by the expression of endogenous counter-regulatory cytokines, such as IL-10. In this study, we defined the role of endogenously-produced IL-10 in a murine model of endotoxemia. Initial studies indicated that LPS administration to mice i.p. induces a significant time-dependent increase in plasma IL-10. Passive immunization with anti-IL-10 serum before LPS administration resulted in substantial increases in endotoxin-induced lethality. Furthermore, the inhibition of IL-10 bioactivity in vivo resulted in a greater and more sustained increase in plasma TNF and macrophage inflammatory protein-2 (MIP-2) levels, as compared with control animals, which was accompanied by early increases in lung polymorphonuclear leukocyte influx and lung capillary leak. Finally, anti-IL-10-mediated lethality was significantly abrogated by concomitant treatment with anti-MIP-2 serum and/or sTNFR:Fc alone or in combination. These observations indicate that TNF and MIP-2 are important cytokine mediators during endotoxemia, and endogenously produced IL-10 is instrumental in down-regulating the overzealous production of both TNF and MIP-2 that occurs in response to systemic endotoxin exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Endotoxin signal transduction in macrophages
Sweet, M. J., & Hume, D. A. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.1.8 · Cited by 793
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461
Yang, S.-R., Wright, J., Bauter, M., Seweryniak, K., Kode, A., & Rahman, I. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00308.2006 · Cited by 391
Hypoxia-Inducible Factors as Essential Regulators of Inflammation
Imtiyaz, H. Z., & Simon, M. C. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_74 · Cited by 379
Balance of inflammatory cytokines related to severity and mortality of murine sepsis
Walley, K. R., Lukacs, N. W., Standiford, T. J., Strieter, R. M., & Kunkel, S. L. (1996) · Infection and Immunity · doi:10.1128/iai.64.11.4733-4738.1996 · Cited by 366
Self-citationCytokine Production Regulating Th1 and Th2 Cytokines in Hemophagocytic Lymphohistiocytosis
Osugi, Y., Hara, J., Tagawa, S., Takai, K., Hosoi, G., Matsuda, Y., Ohta, H., Fujisaki, H., Kobayashi, M., Sakata, N., et al. (1997) · Blood · doi:10.1182/blood.v89.11.4100 · Cited by 366
The molecular pathogenesis of endotoxic shock and organ failure
Karima, R., Matsumoto, S., Higashi, H., & Matsushima, K. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01430-0 · Cited by 340
Cavaillon, J.-M., Adib-conquy, M., Fitting, C., Adrie, C., & Payen, D. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310015935 · Cited by 336
Haskó, G., Kuhel, D. G., Németh, Z. H., Mabley, J. G., Stachlewitz, R. F., Virág, L., Lohinai, Z., Southan, G. J., Salzman, A. L., & Szabó, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.1013 · Cited by 334
Surfactant Protein-A-Deficient Mice Are Susceptible to Pseudomonas aeruginosa Infection
LeVine, A. M., Kurak, K. E., Bruno, M. D., Stark, J. M., Whitsett, J. A., & Korfhagen, T. R. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.4.3254 · Cited by 317
The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer?
Boomer, J. S., Green, J. M., & Hotchkiss, R. S. (2014) · Virulence · doi:10.4161/viru.26516 · Cited by 317
Regulation of Macrophage Chemokine Expression by Lipopolysaccharide In Vitro and In Vivo
Kopydlowski, K. M., Salkowski, C. A., Cody, M. J., van Rooijen, N., Major, J., Hamilton, T. A., & Vogel, S. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1537 · Cited by 313
Studies with IL-10-/- mice: an overview
Rennick, D. M., Fort, M. M., & Davidson, N. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.4.389 · Cited by 302
IFN-γ Shapes Immune Invasion of the Central Nervous System Via Regulation of Chemokines
Tran, E. H., Prince, E. N., & Owens, T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2759 · Cited by 299
Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation
Madan, R., Demircik, F., Surianarayanan, S., Allen, J. L., Divanovic, S., Trompette, A., Yogev, N., Gu, Y., Khodoun, M., Hildeman, D., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900185 · Cited by 295
Darville, T., O’Neill, J. M., Andrews, C. W., Nagarajan, U. M., Stahl, L., & Ojcius, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.6187 · Cited by 289
IL-10 Is a Major Mediator of Sepsis-Induced Impairment in Lung Antibacterial Host Defense
Steinhauser, M. L., Hogaboam, C. M., Kunkel, S. L., Lukacs, N. W., Strieter, R. M., & Standiford, T. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.392 · Cited by 289
Self-citationCrucial Role of Endogenous Interleukin-10 Production in Myocardial Ischemia/Reperfusion Injury
Yang, Z., Zingarelli, B., & Szabó, C. (2000) · Circulation · doi:10.1161/01.cir.101.9.1019 · Cited by 282
Tsai, W. C., Strieter, R. M., Mehrad, B., Newstead, M. W., Zeng, X., & Standiford, T. J. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.4289-4296.2000 · Cited by 282
Self-citationVascular leak syndrome: a side effect of immunotherapy
Baluna, R., & Vitetta, E. S. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(97)00041-6 · Cited by 280
Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ Receptors
Gerber, J. S., & Mosser, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6861 · Cited by 263
Louis, H., Van Laethem, J.-L., Wu, W., Quertinmont, E., Degraef, C., Van den Berg, K., Demols, A., Goldman, M., Le Moine, O., Geerts, A., et al. (1998) · Hepatology · doi:10.1002/hep.510280621 · Cited by 255
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114
Postinfluenza bacterial pneumonia: Host defenses gone awry
Ballinger, M. N., & Standiford, T. J. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2010.0049 · Cited by 103
Self-citationMatzer, S. P., Baumann, T., Lukacs, N. W., Röllinghoff, M., & Beuscher, H. U. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4635 · Cited by 48
Self-citation
Metadata
- Authors
- Standiford, T. J., Strieter, R. M., Lukacs, N. W., & Kunkel, S. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-08
- Volume
- 155
- Issue
- 4
- Pages
- 2222-2229
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1494575416
- Cited by
- 275
- References
- 0
- FWCI
- 7.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.